When clinical trial teams screen for "tech-savvy, engaged" participants, they're often running a second, unwritten eligibility criterion that systematically excludes the populations the study drug is actually meant to treat.
Rakshinda Mujeeb, PharmD, CRCP, ACRP-CP
Advertisement
Rakshinda Mujeeb, PharmD, CRCP, ACRP-CP®, Research Projects Manager, Mediclinic Middle East.
Articles by Rakshinda Mujeeb, PharmD, CRCP, ACRP-CP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Control Plane for Agentic Clinical Operations: Governing Autonomous Digital Actors in Regulated Trials
2
HHS Launches SURPASS Program and Three Complementary Initiatives to Transform Clinical Trial Design and Infrastructure
3
Hierarchical Endpoints in Cardiology: How Much Treatment Benefit, and From Where
4
What ClinOps Professionals Just Starting With AI Should Keep Top of Mind
5